SIEGALL CLAY B (President and CEO) purchased 0.7% of their position (4.73K shares) of IMMUNOME INC. on the open market
Open‑market purchase worth $100.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/30/2025ACC: 0001167496-25-000010
DirectorOfficer· President and CEO
Since Oct 2023
+4.73K
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.73K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.73K
Price / share
$21.15
Trade value
$100.02K
% of position
0.7%
12/30/2025
660.52K→665.25K
Total
Net shares
+4.73K
Net value
$100.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/30/2025 | P · Purchase | +4.73K | $21.15 | $100.02K | 0.7% | 660.52K | 665.25K |
| Total | +4.73K | $100.02K | ||||||
Derivative Transactions0
No derivative transactions reported